Preprint coverage: Vaccinating adolescents in England: a risk-benefit analysis

The UK JCVI committee recently announced that vaccines would not be offered to all 12-17 year olds, as the potential risks were not outweighed by the benefits. Here, we offer a quantitative risk-benefit analysis of vaccines among 12-17 year olds in England, showing that the benefits of vaccination greatly outweigh risks among12-17 year olds in England in the current context.

This Preprint paper has been covered by The Guardian, Daily Mail and iNews this week.

Read the full paper